*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Eribulin Mesilate is a synthetic analog of halichondrin B, functioning as a microtubule dynamics inhibitor. Its core synthesis involves complex chiral construction and mesylation. The molecular formula is <strong>C<sub>48</sub>H<sub>75</sub>NO<sub>16</sub>·CH<sub>4</sub>O<sub>3</sub>S</strong> with CAS No. <strong>206908-02-3</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Manufacturing:</strong> Bulk production for injectable formulations targeting metastatic breast cancer.</li>
<li><strong>Pharmaceutical R&D:</strong> Active Pharmaceutical Ingredient (API) supply for clinical trials in solid tumors.</li>
<li><strong>Distribution:</strong> Global logistics for temperature-controlled API shipment to oncology centers.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly indicated for patients with prior anthracycline exposure. Requires storage at controlled room temperature protected from light. Personnel must utilize PPE due to potential cytotoxicity risks during handling.</p>